GCP
PLRX icon

GSA Capital Partners’s Pliant Therapeutics PLRX Stock Holding History

GSA Capital Partners’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$185K Sell
162,206
-239,886
-60% -$292K 0.01% 1550
2026
Q1 		$507K Sell
402,092
-221,606
-36% -$280K 0.03% 912
2025
Q4 		$761K Buy
623,698
+462,814
+288% +$695K 0.07% 533
2025
Q3 		$238K Buy
160,884
+146,742
+1,038% +$224K 0.02% 1338
2025
Q2 		$16K Sell
14,142
-20,530
-59% -$29K ﹤0.01% 1693
2025
Q1 		$47K Buy
+34,672
New +$210K ﹤0.01% 1551
2023
Q4 		– Sell
-45,587
Closed -$790K – 1823
2023
Q3 		$790K Buy
+45,587
New +$790K 0.07% 525
2023
Q2 		– Sell
-19,206
Closed -$511K – 1849
2023
Q1 		$511K Sell
19,206
-1,053
-5% -$30K 0.05% 706
2022
Q4 		$392K Sell
20,259
-1,976
-9% -$41.3K 0.05% 756
2022
Q3 		$464K Sell
22,235
-50,818
-70% -$972K 0.06% 626
2022
Q2 		$585K Buy
73,053
+4,817
+7% +$30.8K 0.09% 399
2022
Q1 		$478K Buy
68,236
+9,643
+16% +$98.4K 0.06% 559
2021
Q4 		$791K Buy
58,593
+32,726
+127% +$520K 0.1% 320
2021
Q3 		$437K Buy
+25,867
New +$549K 0.04% 779

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

GSA Capital Partners's PLRX Position: Q2 2026 in Review

GSA Capital Partners reduced its Pliant Therapeutics (PLRX) stake by 60% in Q2 2026, selling an estimated $292K and leaving 162,206 shares worth $185K. The position accounts for 0.01% of the portfolio, ranked #1550.

GSA Capital Partners first reported a position in PLRX in Q3 2021 and has held it in 14 quarters since. The position peaked at $791K in Q4 2021. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • GSA Capital Partners held 162,206 shares of Pliant Therapeutics worth $185K as of Q2 2026.
  • GSA Capital Partners sold 239,886 Pliant Therapeutics shares in Q2 2026, an estimated $292K.
  • Pliant Therapeutics made up 0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1550 holding.
  • GSA Capital Partners first reported a position in Pliant Therapeutics in Q3 2021 and has held it in 14 quarters since.
  • GSA Capital Partners's Pliant Therapeutics position peaked at $791K in Q4 2021.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.